Cartiva is the first PMA approved alternative to fusion for arthritis of the big toe joint

FDA Approves Cartiva Synthetic Cartilage Implant (ODTMag)
Cartiva is the first PMA approved alternative to fusion for arthritis of the big toe joint.
Cartiva Inc. announced today that it received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for its Cartiva Synthetic Cartilage Implant (SCI) for arthritis of the big toe joint. The approval allows the Company to begin marketing in the United States the first synthetic cartilage device approved by the FDA.
Cartiva SCI is intended for the treatment of painful arthritis at the base of the big toe, the most common arthrit...